[HTML][HTML] Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation

J Cosedis Nielsen, A Johannessen… - … England Journal of …, 2012 - Mass Medical Soc
Background There are limited data comparing radiofrequency catheter ablation with
antiarrhythmic drug therapy as first-line treatment in patients with paroxysmal atrial …

Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial

JC Nielsen, A Johannessen, P Raatikainen… - Heart, 2017 - heart.bmj.com
Objective The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal
Atrial Fibrillation (MANTRA-PAF) trial compared radiofrequency catheter ablation (RFA) with …

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial

H Walfridsson, U Walfridsson, JC Nielsen… - Ep …, 2015 - academic.oup.com
Abstract Aims The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in
Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an …

Source of inflammatory markers in patients with atrial fibrillation

I Liuba, H Ahlmroth, L Jonasson, A Englund… - Europace, 2008 - academic.oup.com
Aims Elevated levels of C-reactive protein and other inflammatory markers have been
reported in some patients with atrial fibrillation (AF). Whether this finding is related to AF per …

Gender-related differences in patients with atrioventricular nodal reentry tachycardia

I Liuba, A Jönsson, K Säfström, H Walfridsson - The American journal of …, 2006 - Elsevier
The present study sought to assess the extent of gender differences in electrophysiologic
parameters in patients with atrioventricular nodal reentrant tachycardia (AVNRT). The study …

Factors predicting arrhythmia-related symptoms and health-related quality of life in patients referred for radiofrequency ablation of atrial fibrillation: an observational …

E Charitakis, N Barmano, U Walfridsson… - JACC: Clinical …, 2017 - jacc.org
Objectives: The purpose of this study was to correlate the arrhythmia-related symptoms and
health-related quality of life (HRQoL) in patients with atrial fibrillation (AF) who are eligible …

The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy

M Aronsson, H Walfridsson, M Janzon… - EP …, 2015 - academic.oup.com
Aim The aim of this prospective substudy was to estimate the cost-effectiveness of treating
paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with …

[HTML][HTML] Cost-effectiveness of catheter ablation treatment for patients with symptomatic atrial fibrillation

N Eckard, T Davidson, H Walfridsson… - Journal of atrial …, 2009 - ncbi.nlm.nih.gov
Background: Atrial Fibrillation is the most common cardiac arrhythmia. It increases the risk of
thromboembolic events and many atrial fibrillation patients suffer quality of life impairment …

Predictors of improvement in arrhythmia‐specific symptoms and health‐related quality of life after catheter ablation of atrial fibrillation

N Barmano, E Charitakis, JE Karlsson… - Clinical …, 2019 - Wiley Online Library
Background The primary goal of radiofrequency ablation (RFA) of atrial fibrillation (AF) is to
improve symptoms and health‐related quality of life (HRQoL). However, most studies have …

Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and …

H Walfridsson, OG Anfinsen, A Berggren, L Frison… - EP …, 2015 - academic.oup.com
Aims We aimed at examining the acetylcholine-dependent inward-rectifier current (I KAch)
as a target for the management of atrial fibrillation (AF). Methods and results The …